化学
利乐
部分
激酶
二醇
代谢稳定性
立体化学
环己烷
结构-活动关系
组合化学
铅化合物
体外
药物化学
生物化学
有机化学
作者
Wooseok Han,Yu Ding,Zheng Chen,John L. Langowski,Cornelia R. Bellamacina,Alice C. Rico,Gisele Nishiguchi,Jiong Lan,Gordana Atallah,Mika Lindvall,Song Yi Lin,Richard Zang,Paul H. Feucht,Tatiana Zavorotinskaya,Yumin Dai,Pablo D. García,Matthew T. Burger
标识
DOI:10.1021/acs.jmedchem.0c01279
摘要
Overexpression of PIM 1, 2, and 3 kinases is frequently observed in many malignancies. Previously, we discovered a potent and selective pan-PIM kinase inhibitor, compound 2, currently in phase I clinical trials. In this work, we were interested in replacing the amino group on the cyclohexane ring in compound 2 with a hydroxyl group. Structure-based drug design led to cellularly potent but metabolically unstable tetra-substituted cyclohexyl diols. Efforts on the reduction of Log D by introducing polar heterocycles improved metabolic stability. Incorporating fluorine to the tetra-substituted cyclohexyl diol moiety further reduced Log D, resulting in compound 14, a cellularly potent tetra-substituted cyclohexyl diol inhibitor with moderate metabolic stability and good permeability. We also describe the development of efficient and scalable synthetic routes toward synthetically challenging tetra-substituted cyclohexyl diol compounds. In particular, intermediate 36 was identified as a versatile intermediate, enabling a large-scale synthesis of highly substituted cyclohexane derivatives.
科研通智能强力驱动
Strongly Powered by AbleSci AI